As of March 31, 2026, Kapeks Kimya Sanayi AS has 21.37M shares outstanding.
| Shares Outstanding | 21.37M |
As of March 31, 2026, Kapeks Kimya Sanayi AS maintains a current ratio of 2.58, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.12, indicating elevated leverage, while an interest coverage ratio of 35.48 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.58 |
| Quick Ratio | 0.52 |
| Debt / Equity | 6.12 |
| Interest Coverage | 35.48 |
Over the twelve months ended March 31, 2026, Kapeks Kimya Sanayi AS recorded 27.29M in income tax expense. That works out to an effective tax rate of 43.24, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items.
| Income Tax | 27.29M |
| Effective Tax Rate | 43.24 |
These figures cover the twelve months ended March 31, 2026.
| Gross Profit | 250.06M |
| Pretax Income | 63.12M |
As of March 31, 2026, Kapeks Kimya Sanayi AS holds 394.45M in cash and equivalents against 159.37M in total debt, resulting in a net debt position of -274.56M. Total book value stands at 2.60B, with working capital of 1.21B providing operational flexibility.
| Cash & Cash Equivalents | 394.45M |
| Total Debt | 159.37M |
| Net Debt | -274.56M |
| Equity (Book Value) | 2.60B |
| Book Value Per Share | 121.77 |
| Working Capital | 1.21B |
These figures cover the twelve months ended March 31, 2026.
| Free Cash Flow | 78.26M |
| FCF Per Share | 3.66 |
Over the twelve months ended March 31, 2026, Kapeks Kimya Sanayi AS posted a gross margin of 31.49, reflecting its pricing power and cost economics. The operating margin of 11.83 and net profit margin of 4.59 provide insight into operational efficiency.
| Gross Margin | 31.49 |
| Operating Margin | 11.83 |
| Pretax Margin | 7.95 |
| Profit Margin | 4.59 |
Already premium?